NOVELIX PHARMACEUTICALS LIMITED

About

Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	36.91	25.19	48.40	36.36	22.35	20.86	5.30	3.96	0.60	0.84	0.50	0.93	1.95
Expenses	35.60	23.91	47.09	35.66	22.17	20.63	5.17	3.74	1.04	0.69	0.61	1.04	2.14
Operating Profit	1.31	1.28	1.31	0.70	0.18	0.23	0.13	0.22	-0.44	0.15	-0.11	-0.11	-0.19
OPM %	3.55	5.08	2.71	1.93	0.81	1.10	2.45	5.56	-73.33	17.86	-22.00	-11.83	-9.74
Other Income	0.00	0.00	0.00	0.03	0.00	0.00	0.00	-0.08	0.10	0.13	0.09	0.05	0.05
Depreciation	0.07	0.05	0.03	0.01	0.01	0.02	0.00	0.00	0.00	0.01	0.01	0.01	0.01
Interest	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	1.12	1.23	1.28	0.72	0.17	0.21	0.13	0.14	-0.34	0.27	-0.03	-0.07	-0.15
Tax %	-5.36	26.02	21.88	26.39	41.18	14.29	-15.38	0.00	2.94	0.00	0.00	0.00	6.67
Net Profit	1.18	0.91	1.00	0.53	0.11	0.18	0.15	0.13	-0.35	0.28	-0.03	-0.07	-0.17
EPS in Rs	0.49	0.43	0.58	0.37	0.09	0.18	0.15	0.13	-0.35	0.35	-0.04	-0.09	-0.21

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	132.00	31.00	4.00	2.00	1.00	1.00	2.00	4.00	3.00	4.00	1.00	1.00
Expenses	129.00	31.00	4.00	2.00	3.00	4.00	1.00	3.00	3.00	3.00	1.00	1.00
Operating Profit	3.00	0.00	0.00	0.00	-2.00	-3.00	0.00	0.00	0.00	0.00	0.00	0.00
OPM %	2.60	0.50	-6.00	0.00	-151.00	-244.00	12.00	6.00	15.00	5.00	43.00	33.00
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	3.00	0.00	0.00	0.00	-2.00	-3.00	0.00	0.00	0.00	0.00	0.00	0.00
Tax %	25.00	33.00	50.00	0.00	-1.00	0.00	20.00	-32.00	34.00	24.00	31.00	88.00
Net Profit	3.00	0.00	0.00	0.00	-2.00	-3.00	0.00	0.00	0.00	0.00	0.00	0.00
EPS in Rs	1.21	0.08	0.01	-0.07	-1.93	-4.04	0.11	0.31	0.22	0.19	0.12	0.02
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	21.00	10.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00
Reserves	25.00	8.00	-1.00	-1.00	-1.00	1.00	4.00	4.00	4.00	3.00	3.00	3.00
Borrowings	4.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	42.00	10.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	92.00	27.00	7.00	7.00	7.00	9.00	12.00	12.00	12.00	12.00	12.00	12.00
Fixed Assets	3.00	0.00	0.00	0.00	2.00	0.00	0.00	0.00	1.00	1.00	1.00	1.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	3.00	3.00	1.00	4.00	4.00	3.00	3.00	2.00	3.00	1.00
Other Assets	89.00	27.00	4.00	4.00	5.00	5.00	8.00	9.00	9.00	9.00	8.00	9.00
Total Assets	92.00	27.00	7.00	7.00	7.00	9.00	12.00	12.00	12.00	12.00	12.00	12.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash from Operating Activity	-22.00	-14.00	0.00	-2.00	1.00	1.00	1.00	0.00	1.00	-1.00	2.00	0.00
Cash from Investing Activity	-2.00	3.00	0.00	0.00	0.00	0.00	0.00	0.00	-1.00	1.00	-2.00	0.00
Cash from Financing Activity	26.00	11.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Cash Flow	2.00	1.00	0.00	-2.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	-1.00
Free Cash Flow	-26.00	-14.00	0.00	-2.00	-1.00	0.00	1.00	0.00	1.00	-1.00	2.00	-1.00
CFO/OP %	-643.00	-9,771.00	136.00	—	-34.00	-18.00	672.00	-220.00	225.00	-535.00	472.00	-90.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Debtor Days	163.00	216.00	1.00	36.00	32.00	25.00	19.00	216.00	130.00	40.00	4.00	30.00
Inventory Days	42.00	10.00	113.00	222.00	239.00	89.00	39.00	13.00	19.00	28.00	—	0.00
Days Payable	116.00	115.00	0.00	14.00	0.00	4.00	5.00	13.00	54.00	0.00	—	—
Cash Conversion Cycle	88.00	111.00	114.00	244.00	271.00	111.00	54.00	216.00	95.00	68.00	4.00	30.00
Working Capital Days	122.00	197.00	346.00	743.00	647.00	819.00	1,711.00	858.00	932.00	863.00	2,584.00	2,225.00
ROCE %	10.00	1.00	0.00	-1.00	-19.00	-31.00	1.00	1.00	3.00	1.00	1.00	1.00

Shareholding Pattern

% holding — latest first

Holder	Jul 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Promoters	54.29	50.57	49.43	51.97	53.33	52.75	66.56	66.56	66.56	66.54	66.92	66.92
Public	45.69	49.43	50.57	48.01	46.66	47.25	33.44	33.45	33.44	33.46	33.08	33.08
No. of Shareholders	3,127	3,118	2,975	2,994	2,697	2,408	2,484	2,502	2,533	2,569	2,635	2,621

Corporate Actions

No corporate actions recorded.

Announcements

5 filings

Announcement under Regulation 30 (LODR)-Change in Directorate
31 Aug 2026 31 Aug - Board appoints Gnana Prakash Gattu as Whole-time Director for five years from 29 August 2026.
Shareholders Meeting AGM On 30Th September, 2026.
31 Aug 2026 31 Aug - Novelix Pharma 32nd AGM on 30 Sep 2026; book closure 24-30 Sep; e-voting 27-29 Sep.
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 29Th August, 2026
29 Aug 2026 29 Aug - Board approved FY26 report, AGM on 30 Sep 2026, and appointed Gnana Prakash Gattu as Whole-time Director.
Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Saturday, 29Th August, 2026
25 Aug 2026 25 Aug - Board meets 29 Aug 2026 to approve AGM notice, board report, scrutinizer, and consider Whole Time Director appointment.
Announcement Under Regulation 30 (LODR) - Lease Deed
20 Aug 2026 20 Aug - Novelix signed 5-year land lease for micro algae cultivation and glass reactor systems in Telangana.

Shareholding Pattern

Open on BSE

Shareholding Pattern (BSE filings)

Financial Results — Filings

Open on BSE

Financial / Quarterly Results (BSE filings)

Board Filings

Open on BSE

Corporate Announcements & Board Filings (BSE)

Annual Reports

Back to all stocks